Study guide
9.1 Infectious Disease, Neoplasms, Blood, and Endocrine
AAPC Certified Outpatient Coder COC
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current COC Exam Facts 1.2 Exam Day, Format, and Approved Code Books 1.3 COC vs CPC, CIC, and CASCC
2 Medical Terminology
2.1 Word Building: Roots, Prefixes, and Suffixes 2.2 Surgical and Diagnostic Procedure Terms 2.3 Musculoskeletal, Integumentary, and Nervous Terminology 2.4 Cardiovascular, Visceral, Endocrine, and Special-Senses Terminology
3 Applied Anatomy for Facility Coding
3.1 Musculoskeletal and Integumentary Anatomy 3.2 Cardiovascular, Respiratory, and Lymphatic Anatomy 3.3 Digestive and Hepatobiliary Anatomy 3.4 GU, Nervous, Special-Senses, and Endocrine Anatomy
4 Coding Guidelines
4.1 ICD-10-CM Official Guidelines and Conventions 4.2 CPT Conventions, Parenthetical Notes, and Unlisted Codes 4.3 Modifier Principles in Facility Reporting
5 Medicare Coverage and Claim Forms
5.1 Medicare Parts A, B, C, and D 5.2 Medicare as Secondary Payer 5.3 The UB-04 Institutional Claim and Revenue Codes 5.4 The CMS-1500 Professional Claim Contrast
6 OPPS, APC, and Related Payment Methodology
6.1 OPPS and Ambulatory Payment Classifications 6.2 OPPS Status Indicators 6.3 Packaging, Composites, and Comprehensive APCs 6.4 IPPS Contrast, the Inpatient-Only List, and OCE Edits
7 Compliance and Regulatory Requirements
7.1 NCDs, LCDs, and Medical Necessity 7.2 HIPAA Privacy, Security, and Code-Set Rules for Coders 7.3 Advance Beneficiary Notices and Financial Liability
8 ICD-10-CM Structure and Outpatient Rules
8.1 ICD-10-CM Structure, Index, and Tabular Conventions 8.2 Section IV: First-Listed Diagnosis for Outpatient Services 8.3 Z Codes, Screening, Aftercare, and Status
9 ICD-10-CM Medical Chapters
9.1 Infectious Disease, Neoplasms, Blood, and Endocrine 9.2 Mental, Nervous System, Eye, and Ear 9.3 Circulatory and Respiratory Systems 9.4 Digestive, Skin, and Musculoskeletal
10 ICD-10-CM Injury, External Causes, and 7th Characters
10.1 GU, Pregnancy, Perinatal, and Congenital Conditions 10.2 Injury, Poisoning, and External Causes 10.3 Laterality, 7th Characters, and Combination Codes
11 HCPCS Level II
11.1 HCPCS Level II Structure and Modifiers 11.2 Drugs, Biologicals, J-Codes, and C-Codes 11.3 Supplies, DME, Prosthetics, and Orthotics 11.4 G-Codes, Ambulance, Pass-Through Devices, and 2026 Skin Substitutes
12 CPT Navigation and Evaluation and Management
12.1 CPT Book Navigation, Symbols, and Sections 12.2 Emergency Department and Observation Services 12.3 Hospital Outpatient Clinic, Preventive, and Critical Care
13 Radiology, Pathology and Laboratory, and Medicine
13.1 Radiology: Technical Component, Contrast, and Interventional 13.2 Pathology and Laboratory 13.3 Hydration, Therapeutic Infusions, and Injections 13.4 Cardiology Diagnostics and Other Medicine Services
14 Surgical Coding Principles and Modifiers
14.1 Reading the Operative Report for Facility Coding 14.2 Outpatient Hospital and ASC Surgical Modifiers 14.3 NCCI PTP Edits and Medically Unlikely Edits 14.4 Discontinued, Reduced, Bilateral, and Multiple Procedures
15 Integumentary, Musculoskeletal, and Respiratory Surgery
15.1 Integumentary Surgery 15.2 Musculoskeletal Surgery 15.3 Respiratory System Surgery
16 Cardiovascular and Digestive Surgery
16.1 Cardiovascular Outpatient Procedures 16.2 Digestive Endoscopy 16.3 Digestive Operative Surgery
17 GU, Gynecologic, Endocrine, and Hemic Surgery
17.1 Urinary and Male Genital Surgery 17.2 Female Genital and Outpatient Maternity Procedures 17.3 Endocrine, Hemic, Lymphatic, and Mediastinum
18 Nervous, Eye, Ear Surgery and ASC versus HOPD Billing
18.1 Nervous System, Pain Management, and Outpatient Spine 18.2 Eye and Ear Surgery 18.3 ASC versus Hospital Outpatient Department Billing
19 Integrated Case Coding
19.1 Same-Day Surgery Cases 19.2 Emergency Department Cases 19.3 Observation and Hospital Clinic Cases 19.4 Multi-Code-Set Diagnostic and Interventional Cases
9.1 Infectious Disease, Neoplasms, Blood, and Endocrine
Key Takeaways Explain This Topic AI
Section IV first-lists the reason for this hospital outpatient or ASC encounter; chapter-specific notes in FY 2026 ICD-10-CM Official Guidelines Section I.C still control sequencing when they apply.
HIV is coded only when confirmed by the provider: B20 for HIV disease or any HIV-related illness, Z21 for asymptomatic HIV-positive status, and R75 only for inconclusive serology — once B20 has been used, do not return to Z21.
Sepsis uses the systemic infection code (A41.9 if the organism is not specified); R65.2 severe sepsis is additional and is never first-listed; MRSA combination codes such as A41.02 or J15.212 already include resistance, so do not add Z16.11.
If the encounter is chiefly for antineoplastic chemotherapy, immunotherapy, or external beam radiation, first-list Z51.11, Z51.12, or Z51.0 and code the current malignancy additional; anemia associated with the malignancy is sequenced malignancy then D63.0.
Type 2 diabetes combination codes include the type, the body system, and the complication: E11.65 is hyperglycemia, E11.00 is hyperosmolarity without coma, E11.10 is ketoacidosis without coma; do not assign E11.9 when a more specific E11 code is documented.
Last updated: September 2026
Infectious Disease, Neoplasms, Blood, and Endocrine
Quick Answer: For the 15-question AAPC Certified Outpatient Coder (COC) ICD-10-CM domain, Chapters A00–B99 , C00–D49 , D50–D89 , and E00–E89 are less about memorizing every subcategory and more about chapter-specific traps . First-list the reason for this encounter (FY 2026 Official Guidelines Section IV ). Then apply Section I.C.1–4 : confirmed HIV ( B20 versus Z21 ), high-level sepsis and resistant-organism rules, the Neoplasm Table columns (primary, secondary, in situ, history, antineoplastic encounter), anemia in neoplastic disease sequencing, and diabetes mellitus combination codes such as E11.9 versus E11.65 versus hyperosmolar and ketoacidosis subcategories.
This independent ExamFinch section helps learners study International Classification of Diseases, Tenth Revision, Clinical Modification ( ICD-10-CM ) medical-chapter diagnosis rules for hospital outpatient and ambulatory surgery center (ASC) facility coding. It is not a Centers for Medicare & Medicaid Services ( CMS ), National Center for Health Statistics ( NCHS ), or American Academy of Professional Coders ( AAPC ) product, and it does not claim partnership or official review by those organizations. Open the FY 2026 Official Guidelines PDF and the Tabular List; do not treat this page as a substitute for either book.
Why these four chapters show up on facility claims
Same-day surgery, hospital outpatient infusion, and observation stays constantly carry infectious status, a current or historical malignancy, anemia, and diabetes. The Current Procedural Terminology (CPT) code explains the resource; the ICD-10-CM code explains why this visit happened . If you first-list a stable chronic diabetes code when the patient came only for a screening colonoscopy, or if you first-list a personal-history Z code while chemotherapy is still directed at a current primary, you have missed Section IV and Section I.C.2 in the same stroke.
Chapter-specific guidelines apply in all settings unless a later section says otherwise. What changes in the outpatient hospital and ASC is the first-listed test: the condition chiefly responsible for this encounter, after conventions and disease-specific notes. Do not code “probable,” “possible,” or “rule out” infection, cancer, or diabetes as if confirmed. Code to the highest certainty documented for that visit.
Infectious disease — HIV, organisms, resistance, and sepsis (high-level)
Code only confirmed HIV. The provider’s diagnostic statement that the patient is HIV positive or has an HIV-related illness is enough; a printed lab report is not required. That confirmation rule is an exception to inpatient uncertain-diagnosis logic, and it still matters in the outpatient setting because you never invent B20 from a “rule out HIV” note.
Documentation Code concept Outpatient first-listed implication
AIDS, HIV disease, or any HIV-related illness B20 , Human immunodeficiency virus [HIV] disease If this encounter is for the HIV-related condition, B20 is first-listed (with the related illness additional). If the encounter is unrelated (for example, a traumatic injury or an elective hernia repair), first-list the reason for surgery or treatment and report B20 additional.
HIV positive, HIV test positive, no HIV-related illness Z21 , Asymptomatic human immunodeficiency virus [HIV] infection status Z21 is a status code. It is first-listed only when the visit is actually for that status; on a surgical claim it is usually additional.
Inconclusive HIV serology R75 Not a substitute for B20 or Z21.
Prior HIV-related illness Always B20 on later encounters Do not “downgrade” to Z21 or R75 after B20 has been established.
HIV disease on antiretroviral therapy B20 Long-term antiretroviral use may be additionally identified with Z79.899 when that status is documented.
HIV-positive status on antiretroviral therapy, no HIV disease Z21 , plus Z79.899 when long-term therapy is reported Status, not B20.
Once an HIV-related illness has developed, B20 stays . Antiretroviral medication does not, by itself, convert Z21 into B20 or B20 into Z21; the documented disease versus status does.
Infectious agents classified elsewhere. When an infection lives in another chapter and the infection code does not name the organism, an additional code from B95–B97 identifies the agent if the Tabular List asks for it. Do not add a Chapter 1 organism code that duplicates a combination code that already includes the organism.
Infections resistant to antibiotics. Identify documented antibiotic resistance. Assign a code from category Z16 , Resistance to antimicrobial drugs, after the infection code only if that infection code does not already identify the resistance.
Methicillin-resistant Staphylococcus aureus (MRSA) is the classic trap. Sepsis due to MRSA is A41.02 . Pneumonia due to MRSA is J15.212 . Those combination codes already include the organism and the resistance. Do not add B95.62 or Z16.11 (resistance to penicillins) on top of them. When the infection has no combination organism code (for example, a wound infection due to MRSA), assign the site infection plus B95.62 , still without Z16.11. Colonization or carriage without illness is Z22.322 (MRSA carrier), which is not the same as current MRSA infection.
Sepsis, severe sepsis, and septic shock are less common on an ASC claim than in the emergency department or observation, but the guidelines still apply when the condition is documented. For sepsis, assign the underlying systemic infection code; if the organism is not specified, A41.9 , Sepsis, unspecified organism. Do not assign R65.2 , Severe sepsis, unless severe sepsis or associated acute organ dysfunction is documented. R65.2 is never first-listed. Septic shock is sequenced infection first, then R65.21 (or T81.12- for postprocedural septic shock). Urosepsis is not a synonym for sepsis; it has no default Index code — query. Negative blood cultures do not by themselves rule sepsis in or out; query if the diagnostic statement and the cultures conflict. If the reason for the encounter is sepsis plus a localized infection such as pneumonia or cellulitis, the systemic infection is first and the localized infection is additional — unless a more specific chapter note (for example, HIV, obstetrics) takes sequencing priority.
Keep sepsis teaching at this high level on the COC: identify the systemic infection, do not first-list R65.2, do not treat urosepsis as A41.9, and do not stack Z16 onto a combination MRSA code.
Neoplasms — table columns, current versus history, antineoplastic encounters
Chapter 2 holds most benign and all malignant neoplasms. Some benign lesions (the guidelines name prostatic adenomas as the pattern) live in body-system chapters. Coding starts with the record: benign, in situ, malignant, or uncertain behavior . If malignant, find any secondary sites. If a histologic term is documented, look up that term in the Alphabetic Index first so you know which Neoplasm Table column to use; “adenoma,” for example, points you toward the benign column rather than a blind jump into the table. Then verify the code in the Tabular List. Do not paste or memorize the printed table; learn the columns and the sequencing notes.
Situation First-listed concept Additional codes
Treatment directed at the primary site Primary malignancy (for example, C50.411 , malignant neoplasm of upper-outer quadrant of right female breast) Secondary sites if present
Treatment directed at a secondary site only, primary still present Secondary malignancy (for example, C78.01 , secondary malignant neoplasm of right lung) Primary malignancy additional
In situ neoplasm as the reason for surgery In situ code (for example, D05.11 , intraductal carcinoma in situ of right breast) Do not use a C code for the same site if the behavior is in situ
Encounter chiefly for external beam radiation , chemotherapy , or immunotherapy Z51.0 , Z51.11 , or Z51.12 Current malignancy additional. If more than one of those therapies is the reason, one Z51 code is first-listed and the other may be additional.
Insertion of radioactive elements (brachytherapy) The malignancy , not Z51.0 Z51.0 is not assigned for brachytherapy insertion
Primary excised or eradicated, no further treatment to that site, no evidence of remaining primary Category Z85 personal history (for example, Z85.3 , personal history of malignant neoplasm of breast) A remaining metastasis is a current secondary , not history
Primary excised but further surgery, radiation, or chemotherapy is still directed to that site Keep the current primary malignancy code until that treatment is completed History Z85 is premature
Anemia associated with malignancy (treatment is only the anemia): sequence the malignancy first , then D63.0 , Anemia in neoplastic disease. That is an explicit exception to the usual “complication first when only the complication is treated” neoplasm rule.
Anemia associated with chemotherapy, immunotherapy, or radiotherapy (treatment is only the anemia): sequence the anemia first (for example D64.81 , Anemia due to antineoplastic chemotherapy), then the neoplasm, then the adverse-effect code ( T45.1X5- for antineoplastic drugs; Y84.2 when the anemia is an abnormal reaction to radiotherapy).
Dehydration treated alone is sequenced dehydration first, then the malignancy. A surgical complication of neoplasm treatment is first-listed as the complication when treatment is directed at resolving it. A pathologic fracture in neoplastic disease ( M84.5- ) is first-listed when the encounter is for the fracture; if the encounter is for the neoplasm and the fracture is associated, the neoplasm is first.
Symptoms in Chapter 18 that are characteristic of the malignancy do not replace the neoplasm as first-listed. C80.0 (disseminated malignant neoplasm, unspecified) is only for advanced metastatic disease with no known primary or secondary sites specified. C80.1 (malignant primary neoplasm, unspecified) is cancer unspecified and should be rare when a site is knowable.
Blood and blood-forming organs (D50–D89)
Chapter 3 currently has no expanded chapter-specific guideline beyond “reserved for future expansion.” Facility coders still assign anemia, coagulation, and immune-mechanism codes at the highest documented specificity, and they still obey the Chapter 2 anemia-sequencing notes above. D63.0 is the manifestation-style anemia of neoplastic disease; it is not a substitute for iron-deficiency D50.9 or for chemotherapy-induced D64.81 when the record names those causes instead.
Endocrine — diabetes combination codes, use-additional notes, hyperosmolarity versus ketoacidosis
Diabetes mellitus codes in E08–E13 are combination codes : they include the type , the body system affected , and the complication . Assign as many codes from E08–E13 as needed to describe all associated conditions. Sequence them from the reason for this encounter . Age alone does not decide type 1 versus type 2.
If the type is not documented , the default is E11.- Type 2 diabetes mellitus. If the type is not documented but insulin is used, still default to E11.- and add long-term-use codes from Z79 as applicable. Z79.4 (long-term current use of insulin) is not assigned for insulin given only temporarily to control glucose during this encounter. If the patient uses both insulin and an oral hypoglycemic, assign Z79.4 and Z79.84 . If insulin and an injectable non-insulin antidiabetic are both long-term, assign Z79.4 and Z79.85 .
E11.9 , Type 2 diabetes mellitus without complications, is correct only when no diabetic complication is documented. E11.65 , Type 2 diabetes mellitus with hyperglycemia, is the combination code when hyperglycemia is documented without a more specific metabolic crisis. Hyperglycemia is not automatically ketoacidosis and is not automatically hyperosmolarity.
Documented metabolic picture (type 2 examples) Combination code Do not substitute
Type 2 diabetes without documented complication E11.9 Do not add E11.65 “just in case” the glucose is a little high if hyperglycemia is not diagnosed
- Type 2 diabetes with hyperglycemia E11.65 Not E11.9; not E11.10
- Type 2 diabetes with hyperosmolarity without coma E11.00 Not E11.65
- Type 2 diabetes with hyperosmolarity with coma E11.01 Not E11.11
- Type 2 diabetes with ketoacidosis without coma E11.10 Not E11.00
- Type 2 diabetes with ketoacidosis with coma E11.11 Not E11.01
Use additional notes still apply. E11.22 , Type 2 diabetes mellitus with diabetic chronic kidney disease, requires an additional N18.- code for the chronic kidney disease stage. Diabetic retinopathy, neuropathy, and circulatory complication codes are assigned when documented; you may need more than one E11 code at the same visit. FY 2026 also provides E11.A , Type 2 diabetes mellitus without complications in remission, only when the provider documents remission (not a casual “resolved”), and E10.A- for presymptomatic type 1 diabetes. Secondary diabetes ( E08 , E09 , E13 ) follows Tabular “code first” notes for the underlying cause; postpancreatectomy diabetes uses E13.- with E89.1 and Z90.41 as the guidelines instruct.
Facility scenario
Hospital outpatient infusion: current right-breast primary still on a chemotherapy protocol; today’s orders are antineoplastic infusion only. First-list Z51.11 , then the current breast malignancy (not Z85.3 ). Two days later the same patient returns only for transfusion of anemia the provider links to the malignancy, with no antineoplastic drug given. First-list the malignancy , then D63.0 . If instead the anemia is documented as an adverse effect of the chemotherapy and only the anemia is treated, the anemia code is first, then the neoplasm, then T45.1X5- . On a later ASC day for laparoscopic cholecystectomy, type 2 diabetes with hyperglycemia and long-term insulin is additional, not first-listed, unless the diabetes is actually why the patient is there: report E11.65 and Z79.4 , not E11.9 , and not E11.10 without ketoacidosis.
Source
FY 2026 ICD-10-CM Official Guidelines for Coding and Reporting (CMS PDF) — Section I.C.1–4 and Section IV.